Randomized phase III trial of surgery plus neoadjuvant TS-1 and cisplatin compared with surgery alone for type 4 and large type 3 gastric cancer: Japan Clinical Oncology Group Study (JCOG 0501)
Phase of Trial: Phase III
Latest Information Update: 29 Sep 2016
At a glance
- Drugs Cisplatin (Primary) ; Gimeracil/oteracil/tegafur (Primary)
- Indications Gastric cancer
- Focus Therapeutic Use
- 20 Sep 2016 Status changed from active, no longer recruiting to completed.
- 19 Jul 2013 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan record.
- 17 Dec 2009 New source identified and integrated (University Hospital Medical Information Network - Japan).